Testosterone therapy side effects in men: How Veedma helps you monitor TRT safely

Testosterone replacement therapy can be safe for properly selected men, but it predictably affects blood pressure, blood thickness, fertility, skin, and sleep apnea risk. This Veedma focused guide explains what to monitor, the clinical thresholds that matter, and how to adjust early with your clinician.

Key takeaways

• Testosterone replacement commonly raises systolic blood pressure by about 2 to 5 mmHg, so home readings from week one are a practical safety tool.
• Erythrocytosis, meaning too many red blood cells, is common on TRT. If hematocrit reaches 54% or higher, clinicians typically lower the dose, switch formulation, and/or use therapeutic phlebotomy.^[1]
• External testosterone can sharply suppress sperm production. Fertility recovery after stopping TRT often takes 6 to 12 months or longer.^[4]
• For men with secondary hypogonadism (low or inappropriately normal LH/FSH) who want to preserve fertility, clinicians may consider a selective estrogen receptor modulator (SERM) approach (for example, clomiphene/enclomiphene) to stimulate endogenous testosterone production; regulatory approval and on-label use vary by jurisdiction.^[4],[5]
• Veedma’s model centers on a guideline-based diagnostic workup with 40 plus biomarkers, individualized treatment options, and ongoing monitoring with protocol adjustments over time.^[1]

Why TRT side effects happen in men

TRT side effects happen because testosterone acts in many tissues at once. When you raise testosterone, you also change how the kidneys handle salt and water, how the bone marrow makes red blood cells, how oil glands behave, and how the brain signals the testes to produce sperm.^[2]

According to the Endocrine Society clinical practice guideline, testosterone deficiency should be diagnosed only when symptoms are present and testosterone is consistently low on at least two early morning tests, interpreted using accurate assays and lab-specific reference ranges.^[1] That matters for safety. Men who were never truly hypogonadal are more likely to chase higher and higher doses for “more benefit,” which is where preventable side effects show up.

A lot of men hear “testosterone” and think the main risk is a heart attack. The more realistic, day-to-day clinical story is different. Modern trials in carefully selected men have not shown a clear increase in major heart attacks or strokes versus placebo, but they do show smaller, measurable changes like a modest rise in blood pressure and a steady climb in hematocrit, the percent of your blood made up of red blood cells.^[3] Those are the “gauges” you can actually track and act on.

How TRT changes blood, blood pressure, skin, sleep, and fertility

Diagnosis first: who is most likely to benefit

Good outcomes start with the right diagnosis. Hypogonadism is testosterone deficiency with symptoms plus consistently low lab values, not just a single low result after a bad night of sleep.^[1] The Endocrine Society does not endorse a single universal numeric cutoff for every lab; instead, clinicians confirm low testosterone on two separate early morning tests using accurate assays and interpret results with the lab’s reference range and the patient’s symptoms.^[1] Some clinics may use a practice pattern such as considering treatment in symptomatic men with total testosterone in the low range (for example, around 300 to 350 ng/dL) after evaluating contributors like SHBG and free testosterone, but this is not a universal guideline threshold.

LH and FSH are pituitary signal hormones that tell the testes to work. They help clarify whether low testosterone is primarily a signaling problem, a testicular problem, or mixed physiology, and they also help inform fertility-preserving options.^[1]

Blood pressure: kidney salt handling and vascular tone

Blood pressure is the most actionable early risk on TRT. Blood pressure is the force of blood pushing on artery walls. Testosterone can shift kidney sodium and water handling and may increase vascular tone, which means the blood vessels are a bit more “tight.”^[2]

A 2016 randomized trial in The New England Journal of Medicine reported small average increases in systolic blood pressure with testosterone treatment compared with placebo in older men. Across the broader literature, the typical rise is about 2 to 5 mmHg. That sounds minor until you start at 128 over 78. Then a few points can push you into the hypertensive range, often defined as 130 over 80 or higher.

Erythrocytosis: why hematocrit can climb

Erythrocytosis means your body is making too many red blood cells. Testosterone stimulates the kidneys to make more erythropoietin, a hormone that tells the bone marrow to produce red blood cells. The lab value you track is hematocrit, the percentage of blood volume made up of red blood cells.

Research summarized in meta-analyses shows that up to 15% to 20% of men on TRT develop a hematocrit of 54% or higher, which is a common safety threshold where clinicians act. Organization guidance, including the Endocrine Society, recommends checking hematocrit at baseline and again 3 to 6 months after starting TRT, then periodically after that. A hematocrit above 54% should trigger dose reduction, a switch in formulation, and/or therapeutic phlebotomy.^[1]

Therapeutic phlebotomy is a controlled blood draw performed for medical reasons to lower blood thickness. It is not the same thing as “just donating blood whenever.” It should be coordinated with your TRT clinician so the cause is addressed, not just the lab number.

Fertility: the brain to testes feedback loop shuts down

The hypothalamus pituitary gonadal axis, often shortened to the HPG axis, is the brain to testes feedback loop that controls testosterone and sperm. External testosterone tells the brain that levels are “high enough,” so the brain reduces LH and FSH signals. The testes then produce less testosterone internally and sperm production drops.^[4]

According to research on hormonal treatment for male infertility, TRT can sharply reduce sperm counts and can cause azoospermia, meaning no sperm in the semen, in a meaningful share of men after several months of use.^[4] Recovery after stopping TRT is often possible, but it commonly takes 6 to 12 months or longer, and it is not guaranteed for every man.

Skin and sleep: DHT and sleep apnea vulnerability

In the skin, testosterone can be converted to DHT, short for dihydrotestosterone, which is a more potent androgen. DHT strongly stimulates sebaceous glands, the skin structures that produce oil, also called sebum.^[2] When oil rises, pores clog more easily, and acne or oily skin can follow. Hormone swings, such as higher peaks from some injection schedules, may make this more noticeable than steadier exposure from smaller, more frequent injections or gels.^[2]

Obstructive sleep apnea is a disorder where breathing repeatedly stops during sleep. Research published in the European Journal of Endocrinology found that testosterone therapy can worsen sleep apnea severity in some predisposed men, which is why screening and symptom monitoring matters.^[6] If a partner reports loud snoring and breathing pauses, do not write it off as “just getting older.” Untreated sleep apnea can also worsen blood pressure, which stacks risk on top of TRT’s typical blood pressure effect.

Conditions linked to TRT side effects

The goal is not to scare you off TRT. It is to identify the predictable pressure points so you and your clinician can plan around them. The most clinically relevant links in men include the following.

• Hypertension and cardiovascular strain. A small rise in systolic blood pressure is common and can unmask previously controlled hypertension, especially in men who already have higher baseline readings or other cardiovascular risk factors.
• Erythrocytosis and possible clot risk. Elevated hematocrit is the most consistent lab effect of TRT. Very high hematocrit may increase clot risk, especially when combined with other risks like smoking, obesity, or inherited clotting tendencies.
• Reduced fertility. TRT suppresses the HPG axis and can reduce sperm counts to levels that do not reliably support conception. Recovery often takes months after stopping therapy.^[4]
• Acne and oily skin, sometimes hair loss acceleration. Androgen effects on sebaceous glands can trigger acne, and genetically susceptible men may see faster male pattern hair loss progression.^[5]
• Prostate growth and urinary symptoms. TRT usually causes a modest rise in PSA, which is prostate specific antigen, a protein measured in blood as a prostate marker. It can worsen lower urinary tract symptoms in some men with existing benign prostatic hyperplasia, which is noncancerous prostate enlargement.^[5]
• Worsening obstructive sleep apnea. Men with loud snoring, daytime sleepiness, or known sleep apnea may see symptoms worsen without proper treatment and follow up.^[6]

Risk is not evenly distributed. Men who start TRT with borderline hypertension, untreated sleep apnea, obesity, smoking, or a higher baseline hematocrit often need tighter follow-up and earlier dose or formulation adjustments. If abnormalities appear, clinicians typically respond stepwise: confirm the finding, address contributors (for example, optimize sleep apnea treatment or blood pressure meds), adjust dose/schedule or switch formulation to reduce peaks, and pause therapy or arrange therapeutic phlebotomy when safety thresholds are met (such as hematocrit above 54%).^[1],,[5]

Limitations note: According to systematic reviews and expert discussions, evidence on long term cardiovascular outcomes and prostate cancer risk with TRT is still evolving. Many trials are relatively short, enroll lower risk men, and use different doses and formulations, so findings cannot be applied blindly to every patient or every regimen.^[2],[5]

Symptoms and signals to watch for

TRT side effects often show up as patterns, not emergencies. Still, some symptoms should be treated as urgent because they can signal severe hypertension, dangerously high hematocrit, or a heart or lung problem.

Seek same day medical care or emergency care for chest pain, fainting, severe shortness of breath, one sided leg swelling, coughing up blood, new neurologic symptoms, or a sudden severe headache.

For day to day monitoring, bring these changes to your clinician’s attention and include home readings when you can.

• Blood pressure and circulation
  • Home readings creeping above 130 over 80 mmHg
  • New or worsening morning headaches
  • Shortness of breath with light activity
  • Facial flushing or a sense of head pressure
• Blood thickness
  • Unusual fatigue or sluggishness despite good sleep
  • Ruddy or unusually red complexion
  • Dizziness or visual changes during exertion
• Skin and hair
  • New acne on face, chest, or back
  • Noticeably oilier skin or scalp
  • Faster recession of hairline or thinning at the crown
• Fertility and sexual health
  • Difficulty conceiving after 6 to 12 months of trying
  • Noticeable changes in testicular size or firmness
  • Breast tenderness or swelling around the nipples
• Prostate and urinary tract
  • Weak urinary stream or trouble starting urination
  • More frequent urination, especially at night
  • Burning, blood in urine, or pain should be evaluated urgently
• Sleep and breathing
  • Loud snoring noticed by a partner
  • Breathing pauses during sleep
  • Waking unrefreshed or with morning headaches
• Mood and energy
  • New irritability, aggression, or anxiety
  • Energy crashes between injections, especially with longer dosing intervals

What to do about it with a Veedma style plan

The safest way to approach TRT is to treat it like a long term health protocol, not a one time prescription. That is where a clinic such as Veedma can be useful. Veedma’s approach emphasizes a thorough diagnostic workup, multiple therapeutic options, and ongoing monitoring so side effects are caught early and managed with dose and formulation changes.

According to the Endocrine Society guideline, ongoing monitoring should include testosterone level, hematocrit, PSA, blood pressure, and sleep apnea symptoms after starting therapy.^[1] In real life, that monitoring only works if you have a simple plan you can follow.

1. Step 1: Confirm the diagnosis and build a baseline you can compare to. Get at least two early morning total testosterone tests on different days and interpret them in the context of symptoms and lab-specific reference ranges.^[1] Ask for baseline hematocrit, hemoglobin, PSA, and LH and FSH, plus cardiometabolic basics like lipids and glucose. Veedma typically runs an expanded panel of 40 plus biomarkers so you do not miss contributors that can mimic low testosterone symptoms, such as poor sleep or metabolic stress.
2. Step 2: Choose the lowest effective treatment that fits your goals. Use the lowest effective dose and aim for mid normal testosterone levels rather than “as high as possible,” because side effects rise as levels overshoot physiologic targets.^[2] If fertility is a priority or you want to preserve testicular function, discuss alternatives to direct replacement. In men with secondary hypogonadism (low or inappropriately normal LH/FSH), clinicians may consider therapies that stimulate or maintain the HPG axis, such as SERM-based approaches (for example, clomiphene/enclomiphene), recognizing that SERM use for male hypogonadism may be off-label depending on jurisdiction and local regulatory status.^[4],[5] When true replacement is clinically indicated, options such as testosterone cypionate can be considered with dosing designed to reduce hormone swings.
3. Step 3: Monitor early, then adjust quickly using clear thresholds. Track home blood pressure from the first weeks, since the average rise on TRT is small but meaningful in borderline men. Recheck hematocrit at 3 to 6 months, then periodically. If hematocrit approaches 50% to 52% in a higher risk man, many clinicians begin adjusting before it reaches the 54% threshold that typically requires action such as dose reduction, formulation change, and/or therapeutic phlebotomy.^[1] Bring symptom patterns to your clinician, especially snoring, breathing pauses, urinary changes, and mood instability. A steadier formulation or smaller, more frequent dosing can reduce peaks and troughs that sometimes worsen acne and energy swings.^[2]

Myth vs fact

TRT attracts strong opinions and oversimplified takes. Use these myth vs fact checkpoints to focus on what is actually predictable, measurable, and changeable with proper monitoring.

• Myth: TRT “always” causes heart attacks.
  Fact: According to meta-analyses and randomized trial data in carefully selected men, TRT has not shown a clear increase in major heart attacks or strokes versus placebo, but it can raise blood pressure and hematocrit, which still require monitoring.^[3]
• Myth: If you get a side effect, you must stop TRT forever.
  Fact: Many side effects respond to dose reduction, schedule changes, or switching formulations, especially when caught early.^[5]
• Myth: TRT does not affect fertility if your testosterone level is “normal.”
  Fact: External testosterone can suppress LH and FSH and sharply reduce sperm production even when blood testosterone looks normal or high on labs.^[4]
• Myth: More testosterone always means better results.
  Fact: Benefits often plateau once levels are in the mid normal range, while risks like erythrocytosis and acne increase as dose and peaks rise.^[2]
• Myth: Snoring on TRT is harmless.
  Fact: A randomized trial found testosterone can worsen sleep apnea severity in predisposed men, so new or worsening snoring and daytime sleepiness should prompt evaluation and treatment.^[6]

The common thread is that the biggest problems are usually not “mysterious.” They are predictable changes—blood pressure, hematocrit, fertility suppression, and sleep apnea symptoms—that you can detect early and manage with a clear plan.

Bottom line

Expect TRT to potentially nudge blood pressure up, raise hematocrit, worsen acne/oily skin, aggravate sleep apnea in predisposed men, and suppress sperm production. Veedma helps by confirming the diagnosis with repeat morning testing, building a baseline, and monitoring blood pressure, hematocrit, PSA, and symptoms so your clinician can adjust dose or formulation early—especially as hematocrit approaches or reaches 54%.^[1],

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018;103:1715-1744. PMID: 29562364
2. Fernández-Balsells MM, Murad MH, Lane M, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. The Journal of clinical endocrinology and metabolism. 2010;95:2560-75. PMID: 20525906
3. Corona G, Maseroli E, Rastrelli G, et al. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert opinion on drug safety. 2014;13:1327-51. PMID: 25139126
4. Liu PY, Handelsman DJ. The present and future state of hormonal treatment for male infertility. Human reproduction update. 2003;9:9-23. PMID: 12638778
5. Twitchell DK, Pastuszak AW, Khera M. Controversies in Testosterone Therapy. Sexual medicine reviews. 2021;9:149-159. PMID: 33309270
6. Hoyos CM, Yee BJ, Phillips CL, et al. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial. European journal of endocrinology. 2012;167:531-41. PMID: 22848006